Media – ingenion – cymactive

Ingenion Medical announces CE Mark for cymactive™ 2.0R, the company’s novel indwelling catheter designed to mimic natural urination

With the CE Mark, the company can start European-wide sales and marketing of the company’s innovative first catheter, indicated for men experiencing chronic, non-neurogenic urinary retention. A disruptive new device [...]

INGENION MEDICAL HIRES CHIEF OPERATING OFFICER

LONDON, UK – Ingenion Medical Limited announces that Susan Finch joined the senior management of the company as Chief Operating Officer to support the pre-commercialization activities and launch of its groundbreaking [...]

INGENION MEDICAL HIRES COMMERCIAL DIRECTOR

LONDON, UK – Ingenion Medical Limited announces that Tim Maloney has joined the senior management of the company as Commercial Director to support the pre-commercialization activities and launch of its ground-breaking CymActive [...]

INGENION MEDICAL AND ESNEFT WIN £149,950 I4I CONNECT GRANT FROM NIHR TO ADDRESS CHRONIC MALE INCONTINENCE

LONDON, UK – 28 March, 2022 – Ingenion Medical Limited, today, announces that with its co-applicant, the East Suffolk and North Essex Foundation Trust (ESNEFT), the UK NIHR’s i4i Connect programme [...]

INGENION MEDICAL WINS £277,000 INNOVATE UK SMART GRANT TO ADDRESS FEMALE INCONTINENCE

LONDON, UK – 21 March, 2022 – Ingenion Medical Limited, today, announces it has been awarded a £277,000 SMART grant from Innovate UK, the country’s innovation agency. The funding will [...]

INGENION MEDICAL WINS INNOVATE UK GRANT FOR CE MARKING ITS NOVEL URINARY CATHETER

London, UK – 06 November, 2020 – Ingenion Medical Limited, today, announces it has been awarded nearly £100,000 in grant funding from Innovate UK, the country’s innovation agency.

EDWARD CAPPABIANCA APPOINTED AS CEO